Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

CNO Financial (CNO) Suffers From Pricing Pressure, High Debt

Published 07/03/2017, 08:51 AM
Updated 07/09/2023, 06:31 AM

Despite being a top-tier Multi-line insurer, CNO Financial Group, Inc’s (NYSE:CNO) financial results are highly susceptible to low market share in some product lines that limit business opportunities, high debt level and pricing pressure.

The company faces underwriting and pricing challenges in the long-term care business. The low interest rate environment resulted in spread compression and put pressure on margins. Although the company’s strategic priorities include reduction of exposure to long-term care business, we do not expect any significant improvement in this front in the coming quarters as the pricing pressure is expected to persist for a while.

CNO Financial funds its operations and repays debt very frequently. The cash required for these mostly comes from its debt funds. The debt-to-capital ratio has also been deteriorating over the years due to the decline in capital from losses associated with the sale of CLIC and debt repayments. The high level of debt not only increases financial risk but also makes additional borrowing costly in the future.

Despite occupying the ninth position in the list of the top writers in the individual long-term care insurance business, CNO Financials’ market share is limited to only 3% compared with the top eight writers that hold almost 87%.

The stock also looks overvalued. Over last one year, its price to earnings (PE) ratio has been 15%, above the industry’s level of 13%. Apart from being overvalued compared to the broader industry, this is at the upper end of its own range of 10.95-15.87 over the same time frame.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Reflective of these headwinds, shares of CNO Financial have gained 20% over last one year, underperforming the Zacks categorized Multi-Line Insurance industry’s rally of 36%. However, we expect CNO Financial to retain its face value on the back of positives that include the company’s strong Washington National segment, growth initiatives as well as solid fundamentals.

Zacks Rank and Stocks to Consider

CNO Financial presently has a Zacks Rank #4 (Sell).

Some better-ranked stocks in the insurance industry include Assurant, Inc. (NYSE:AIZ) , Cigna Corporation (NYSE:CI) and FBL Financial Group, Inc. (NYSE:FFG) . Each of the stock carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Assurant offers risk management solutions for housing and lifestyle markets worldwide. The company has delivered positive surprises in three of the last four quarters with an average beat of 6.82%.

Cigna provides insurance plus related products and services in the United States and internationally. The company has delivered positive surprises in three of the last four quarters with an average beat of 1.35%.

FBL Financial sells individual life insurance and annuity products. The company has delivered positive surprises in two of the last four quarters with an average beat of 1.98%.

5 Trades Could Profit ""Big-League"" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Assurant, Inc. (AIZ): Free Stock Analysis Report

Cigna Corporation (CI): Free Stock Analysis Report

CNO Financial Group, Inc. (CNO): Free Stock Analysis Report

FBL Financial Group, Inc. (FFG): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.